Table 2.
Pharmacokinetic parameters for bupivacaine after administration of EXPAREL and lidocaine/epinephrine solution (4 : 4 dose ratio).
| Time interval (min)a | Parameters for plasma bupivacaine | |
|---|---|---|
| (% change from bupivacaine control) | ||
| AUC0−24 hr (hr·ng/mL) | C max (ng/mL) | |
| 0 | 2,240 ± 721 | 519 ± 230 |
| 5b | 4,370 (+95%) (2,980–5,770) |
5,730 (+1,000%) (3,690–7,770) |
| 10 | 3,370 ± 1,980 (+50%) | 865 ± 488 (+67%) |
| 20 | 2,100 ± 445 (−6%) | 412 ± 113 (−21%) |
| 40 | 2,150 ± 410 (−4%) | 422 ± 119 (−19%) |
a N = 3 per group (unless noted); b N = 2; one animal received 55% of the intended dose of EXPAREL. Data from this animal were not used in calculation of means.